Related Experiment Videos
Drug-Induced Liver Injury by Selective Androgenic Receptor Modulators
Joan Ericka Flores1, Shivakumar Chitturi1,2, Sarah Walker1
1Canberra Hospital Garran ACT Australia.
Hepatology Communications
|March 7, 2020
Abstract:
Selective androgenic receptor modulators (SARMs) have not been approved by the U.S. Food and Drug Administration but they are heavily promoted as alternatives to androgenic anabolic steroids. We present two cases of liver injury associated with SARMs.